Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

699
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
699
Drug Therapy01:28

Drug Therapy

445
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
445
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

1.2K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.2K
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

1.3K
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
1.3K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

793
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
793

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Assesment of patient competence in psychiatry: an overview of recent instruments].

Tijdschrift voor psychiatrie·2026
Same author

Increased 1-deoxysphingolipids caused by an altered plasma alanine to serine ratio are associated with metabolic dysfunction-associated steatotic liver disease (MASLD).

Metabolomics : Official journal of the Metabolomic Society·2025
Same author

[The usefulness of therapeutic drug monitoring during treatment with second-generation antidepressants].

Tijdschrift voor psychiatrie·2025
Same author

[Neuropsychiatric associations in Belgium: from foundation to separation (1869-2008)].

Tijdschrift voor psychiatrie·2024
Same author

[Sustainability in Flemish and Dutch mental health care].

Tijdschrift voor psychiatrie·2023
Same author

Euthanasia of a person with a psychiatric disorder does not violate the European Convention on Human Rights (<i>Mortier v. Belgium</i> [no. 78017/17]).

European psychiatry : the journal of the Association of European Psychiatrists·2022

Related Experiment Video

Updated: Apr 28, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K

Belgian consensus on metabolic problems associated with atypical antipsychotics.

A De Nayer1, M De Hert, A Scheen

  • 1Hôpital Sainte-Thérèse, Montignie sur Sambre, Belgium.

International Journal of Psychiatry in Clinical Practice
|June 17, 2014
PubMed
Summary

Second-generation antipsychotics (SGA) pose metabolic risks like diabetes. This workshop provided recommendations for psychiatrists on managing these risks, patient counseling, and physician collaboration.

Keywords:
Consensusdiabetesdyslipidemiametabolicsecond-generation antipsychotics

More Related Videos

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Na&#239;ve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

13.6K
Homogeneous Time-resolved F&#246;rster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

8.3K

Related Experiment Videos

Last Updated: Apr 28, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Na&#239;ve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

13.6K
Homogeneous Time-resolved F&#246;rster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

8.3K

Area of Science:

  • Pharmacology
  • Endocrinology
  • Psychiatry

Background:

  • Second-generation antipsychotics (SGA) are associated with increased risks of metabolic disorders.
  • These risks include impaired glucose tolerance, diabetes mellitus, and dyslipidemia.
  • Management strategies for these adverse effects are crucial for patient care.

Purpose of the Study:

  • To review current information on metabolic risks associated with SGA use.
  • To develop clinical recommendations for psychiatrists regarding SGA initiation, maintenance, and treatment adjustments.
  • To provide guidance on patient counseling and interdisciplinary collaboration.

Main Methods:

  • A workshop involving psychiatrists, diabetologists, and pharmacists.
  • Review of the latest scientific information on SGA-induced metabolic complications.
  • Formulation of consensus-based recommendations.

Main Results:

  • Identified key metabolic risks associated with specific SGAs.
  • Outlined strategies for monitoring and managing metabolic changes.
  • Provided guidance on dose adjustments and alternative treatments when complications arise.

Conclusions:

  • Effective management of SGA-related metabolic disorders requires proactive monitoring and intervention.
  • Clear recommendations are needed for psychiatrists to optimize patient safety.
  • Enhanced collaboration between mental health professionals and diabetologists is essential.